Case Study: Pfizer’s Arena acquisition – A $6.7B deal
Posted on20 Dec 2021
Tagsacquisition, acquisition in pharma, largest ever pharma deal, pfizer, Pfizer strategic deal, pharma acquisition, pharma deal, pharma strategic deal
Comments0
Pfizer will acquire Arena Pharmaceuticals for $6.7 billion to expand its pipeline of immuno-inflammatory disease drugs in development. Why Pfizer acquired Arena?... Read More
AstraZeneca – Alexion $39 billion deal
Posted on15 Dec 2020
Tagsacquisition in pharma, global pharma deals, largest ever pharma deal, monoclonal antibody, pharma deal, ravulizumab, Soliris, Ultomiris
Comments0
AstraZeneca has agreed to buy US drugmaker Alexion Pharmaceuticals for $39 billion to bolster its positions in immunology and rare diseases. Alexion... Read More
Pfizer to acquire Allergan for 150 Billion
Acquiring Company: Pfizer Acquired Company: Allergan Deal Value: $150 billion (Approx.) Few facts about the deal 1. The deal will be the... Read More